pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4526 |
Genomic Coordinates | chr18: 13611114 - 13611200 |
Description | Homo sapiens miR-4526 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4526 | ||||||||||||||||||||||||
Sequence | 54| GCUGACAGCAGGGCUGGCCGCU |75 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZNF25 | ||||||||||||||||||||
Synonyms | KOX19, Zfp9 | ||||||||||||||||||||
Description | zinc finger protein 25 | ||||||||||||||||||||
Transcript | NM_145011 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZNF25 | |||||||||||||||||||||
3'UTR of ZNF25 (miRNA target sites are highlighted) |
>ZNF25|NM_145011|3'UTR 1 GATGAGTTGGGAAATTCTCTTGACTGAATTAATCCTTCAAAACAATCAGATAATTCACACAAGAGGTACACCTTATGAAT 81 CGCATCAATAGAGGGAAATTTTCAGCTACAATCTTTGCTCTCTCTGTGTATCAGCAAATACATAGAGAGATTCTGTACAT 161 TTATTTGGGAGAAAATTTTATCATATTTTAGGCTTTTCTAAATATTAGATAATATAGATGGCAGAAGTCATGCAAATTGT 241 AAAACAGGAAGGAAACCTTTCAGAAGTCATACTTTTGTTTTGCAACATAGAAGTCACACAGGAGAAAAATCCTGTAAGTA 321 AAACGAATGTCAAGACATTTTCTGTCAGGGCAGCCAGCTGTAGACATCCAAAAGCTCACAAATGAGAAGCTCCTTGAGTA 401 TCTAGAAATCTCTTTACACAATTGGAGCTCATGTACTAGAGAATTCAAAGGGATAACTGCAAAGACACTGGTAGATATAG 481 AAGCCTTTATTAAGAATTGATGTTTCATTCAATTTCAGATCACTGGTACTTGGATAGATATTTTAAATATTTGGAAGGTG 561 TTCAATAAAAATTCAAATAATTTGTACTGAGGGAAACAGTTATACTACAAATCATGTTGCAGATCTGATGCCGAGATTGC 641 TCTATTTTAAAAGGAAACCTGCAAATGTCTACATATATGAAGCTTTTAAAAAGCACAAGTTATCAGGCAACATCATTAAA 721 CATACATTAAATGTCTGTTAGCATATAGGATTTTGTGCGTATGTGAGTGTGCTATAACATGTAACTTGCGGATGTTCAGC 801 GTGCATGTGGAATCCATCCATAATGGTACATAGCGAAATAATATAATCTTAGTTCAGTAACTATTATGTGTATGAAGATG 881 TTGCACATTAAGTCTCAGTAGTGACTCTGGTTGTTAATATTTGTATTGTAAGTGTAATATTCCTTTTAAATTATAAGGCA 961 TCTTTTTATCCTTTTTTGTGTTTGTAAATGGATATAGACAGTGGTAATAACTAATCCTTCAAAAATAAGTTAAAATGTTT 1041 TTGTAAAATTTTCAAATGTCAGTCAAGTTTTGCATTAGGGACACATTTATATATAGCAAAAGCCTGAGCTGTTTTTAAAC 1121 AGCTAAAAACAGTAGTATTTATTACAATCTCCACAATGAAAACAAATAGTGCAATGTAAGAAATATTATGTATCTTACTG 1201 TTGATGTGTGAGCAGGGAGCAGAGCTATCTGCATTTGTATTTAGTGTGAGAGTCCTAAATGTTCTTCACCAACTTTTTCT 1281 TCCTCATAGAAGCAACATGGCATAGTTAAGGGTGTGGACTCTGGGCTCCTGCTGCCTGGGCCCCGATTCCAGCATGGGGC 1361 ATGCTACTTAATATCTCTGTGCCTCAGTTCCCATCCCATAAAAGAGTAGTGATAGTGACAACATCTTAGGATTGCTTTGA 1441 GGTCTAAATGAGTTAACATTTTCAAAGCACTTAGAATAGTGTCTGAGACACAAGAGCTATATGTTAGAGGTTATCATCAT 1521 TATTTGTATTTTGTGAATTACGCTGCAAAAAAAAAAAAAATGTTGGCTACCCAACATTCATTCCCCACCTTCTTGCTGCC 1601 AGTGCCTTGATTTGGTTGTTTGTTGTTTGTTTGTTTTCCTACAAGTGATTTAGGGGCAGATCCTGACTACACTAAGTCAG 1681 GGTTTGACAAATGACAGTCCATCAGACAGATCTGGCCCACTACCCATTTTTGTATCCTGCAAGCTAAGAATGGTTTTATA 1761 TTTCTAAATGGTTGAAAGAATCAAAGAATATTGTGACACATGAAAATTATATGATATTCAAATTTCAGTGTCCATAAATA 1841 AAGTTTTGAAAACATGAATACAAACAAAAAACACCTATTTATGTTTGACCTGTGGCTGTCTTTGCACTACCCCAGCAGAG 1921 TTGAGTAGTTGTAGCAGACACCACATGCCCTTGAGCCTAAGATCTAGCACTTTACAAAGTAAGTTTTTCTGTTACTTAGA 2001 GCTGAAAATAAAAGCAATGTAGAGTTACGCTTTTATAAGTATTTCATGTTTCAGAAATGATGCATACAGCAATTTGTAGG 2081 TGGGTGGTTTTTTGCAGTATATTTATTTTGTGCATTATATTTATATGTTAAGAGCCTGAGCTTAGAAGTATTTTTTTCAA 2161 AGAAATGTGTTTTTTACTTGCTAAATTGTCATAACATCAAAACAAGAAATTTCTTGATGGAATGTAGCAGTAAACATATG 2241 AAATAAACATTGTCTAAATTAAGTCGAATTGTTCATTGATACTGCCCCACAGTATTCCTTTGTTTTCTCCCAAATCAATG 2321 GCCAGTTTTCCCTGTATCATTTTATAATTTTCTTTCTATCCCATAAGATACCATTGGTAAGTCATACTTAGCTAACGTAA 2401 CCCAATAACAAAAAACTTACAATACCCAATTCCATCAGCTACATTACTAGTAATCTATAAAATTATTGCCTGCACTTCAT 2481 GTAATTGTCATATGCTGCTACAATCTAAACCTGCCAGCGTCTTACTTCCCCTTCCTAATAAAGACTTTCATTGAT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | BC-1 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796037. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
CLIP-seq Support 1 for dataset GSM796037 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-1 / 4-Thiouridine |
Location of target site | ENST00000302609.7 | 3UTR | UCAAGACAUUUUCUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
60 hsa-miR-4526 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT080216 | PRKACB | protein kinase cAMP-activated catalytic subunit beta | 2 | 2 | ||||||||
MIRT100350 | DDX39B | DExD-box helicase 39B | 2 | 2 | ||||||||
MIRT445480 | KDM6A | lysine demethylase 6A | 2 | 2 | ||||||||
MIRT450233 | ZNF25 | zinc finger protein 25 | 2 | 2 | ||||||||
MIRT465783 | TMOD3 | tropomodulin 3 | 2 | 8 | ||||||||
MIRT466253 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | 2 | 2 | ||||||||
MIRT470395 | PPP1R16B | protein phosphatase 1 regulatory subunit 16B | 2 | 2 | ||||||||
MIRT470442 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 8 | ||||||||
MIRT476323 | GLTSCR1L | BRD4 interacting chromatin remodeling complex associated protein like | 2 | 2 | ||||||||
MIRT479706 | CCNT1 | cyclin T1 | 2 | 2 | ||||||||
MIRT481925 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT484016 | ZNF776 | zinc finger protein 776 | 2 | 4 | ||||||||
MIRT497022 | INO80B | INO80 complex subunit B | 2 | 2 | ||||||||
MIRT502526 | EPHA2 | EPH receptor A2 | 2 | 4 | ||||||||
MIRT513497 | SSR1 | signal sequence receptor subunit 1 | 2 | 6 | ||||||||
MIRT517846 | RPS4X | ribosomal protein S4, X-linked | 2 | 4 | ||||||||
MIRT533734 | TMEM200C | transmembrane protein 200C | 2 | 2 | ||||||||
MIRT535904 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT537537 | EZR | ezrin | 2 | 2 | ||||||||
MIRT538756 | CACUL1 | CDK2 associated cullin domain 1 | 2 | 2 | ||||||||
MIRT540307 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT545510 | EPT1 | selenoprotein I | 2 | 2 | ||||||||
MIRT548829 | CHIC1 | cysteine rich hydrophobic domain 1 | 2 | 2 | ||||||||
MIRT569600 | TRIM29 | tripartite motif containing 29 | 2 | 2 | ||||||||
MIRT572462 | ZNF516 | zinc finger protein 516 | 2 | 2 | ||||||||
MIRT575457 | Ints2 | integrator complex subunit 2 | 2 | 3 | ||||||||
MIRT609411 | SLC25A45 | solute carrier family 25 member 45 | 2 | 2 | ||||||||
MIRT609622 | TRPC4AP | transient receptor potential cation channel subfamily C member 4 associated protein | 2 | 2 | ||||||||
MIRT609666 | INTS2 | integrator complex subunit 2 | 2 | 3 | ||||||||
MIRT609994 | PIGS | phosphatidylinositol glycan anchor biosynthesis class S | 2 | 2 | ||||||||
MIRT611691 | NODAL | nodal growth differentiation factor | 2 | 2 | ||||||||
MIRT615720 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT616383 | C1orf87 | chromosome 1 open reading frame 87 | 2 | 2 | ||||||||
MIRT616593 | KLHL9 | kelch like family member 9 | 2 | 2 | ||||||||
MIRT628162 | HIP1 | huntingtin interacting protein 1 | 2 | 2 | ||||||||
MIRT628376 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | 2 | 2 | ||||||||
MIRT629203 | PAPOLA | poly(A) polymerase alpha | 2 | 2 | ||||||||
MIRT635006 | ADPRH | ADP-ribosylarginine hydrolase | 2 | 2 | ||||||||
MIRT645493 | TRIM63 | tripartite motif containing 63 | 2 | 2 | ||||||||
MIRT646750 | MUC4 | mucin 4, cell surface associated | 2 | 2 | ||||||||
MIRT649613 | ITPKC | inositol-trisphosphate 3-kinase C | 2 | 2 | ||||||||
MIRT656228 | MFSD6 | major facilitator superfamily domain containing 6 | 2 | 2 | ||||||||
MIRT658196 | FBXO44 | F-box protein 44 | 2 | 2 | ||||||||
MIRT661757 | MICA | MHC class I polypeptide-related sequence A | 2 | 2 | ||||||||
MIRT662866 | UPF3A | UPF3A, regulator of nonsense mediated mRNA decay | 2 | 2 | ||||||||
MIRT666738 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT690391 | PARP15 | poly(ADP-ribose) polymerase family member 15 | 2 | 2 | ||||||||
MIRT699795 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT700033 | RPL22 | ribosomal protein L22 | 2 | 2 | ||||||||
MIRT701741 | MTDH | metadherin | 2 | 2 | ||||||||
MIRT702330 | KMT2A | lysine methyltransferase 2A | 2 | 2 | ||||||||
MIRT702672 | IRS2 | insulin receptor substrate 2 | 2 | 2 | ||||||||
MIRT708730 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT709230 | GPSM2 | G protein signaling modulator 2 | 2 | 2 | ||||||||
MIRT717503 | UFL1 | UFM1 specific ligase 1 | 2 | 2 | ||||||||
MIRT718533 | PIGQ | phosphatidylinositol glycan anchor biosynthesis class Q | 2 | 2 | ||||||||
MIRT719845 | MON1B | MON1 homolog B, secretory trafficking associated | 2 | 2 | ||||||||
MIRT720957 | TMEM151B | transmembrane protein 151B | 2 | 2 | ||||||||
MIRT724816 | MSX2 | msh homeobox 2 | 2 | 2 | ||||||||
MIRT725369 | MTF2 | metal response element binding transcription factor 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|